Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Current Assets: 2013-2025

Historic Current Assets for Ocular Therapeutix (OCUL) over the last 12 years, with Sep 2025 value amounting to $387.0 million.

  • Ocular Therapeutix's Current Assets fell 18.19% to $387.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $387.0 million, marking a year-over-year decrease of 18.19%. This contributed to the annual value of $441.0 million for FY2024, which is 89.89% up from last year.
  • Per Ocular Therapeutix's latest filing, its Current Assets stood at $387.0 million for Q3 2025, which was down 10.71% from $433.4 million recorded in Q2 2025.
  • In the past 5 years, Ocular Therapeutix's Current Assets registered a high of $519.8 million during Q1 2024, and its lowest value of $100.7 million during Q2 2023.
  • In the last 3 years, Ocular Therapeutix's Current Assets had a median value of $387.7 million in 2025 and averaged $338.3 million.
  • Its Current Assets has fluctuated over the past 5 years, first crashed by 38.64% in 2023, then surged by 395.06% in 2024.
  • Ocular Therapeutix's Current Assets (Quarterly) stood at $191.3 million in 2021, then plummeted by 32.24% to $129.6 million in 2022, then spiked by 79.16% to $232.2 million in 2023, then spiked by 89.89% to $441.0 million in 2024, then declined by 18.19% to $387.0 million in 2025.
  • Its Current Assets was $387.0 million in Q3 2025, compared to $433.4 million in Q2 2025 and $387.7 million in Q1 2025.